The need for lead extraction has increased exponentially in the last decade due to
greatly increased “total lead exposure time.” The increased total lead exposure time
is the result of new indications for device treatment, device therapy involving more
leads per patient, and longer average patient life. Improved general lead reliability
noted over recent years may have decreased slightly the need for extraction; however,
this effect is more than countered by recent advisories, recalls, and increased complication
rates, probably related to many new centers offering device treatment. Total lead
exposure time still is rising, especially in the United States, mainly due to increasing
rates of implantable cardioverter-defibrillator (ICD) and cardiac resynchronization
therapy (CRT) lead implantation. The implantation rates for all types of devices are
lower in Europe than in the United States; thus, the need for extraction can be expected
to be higher in the United States than in Europe.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Heart RhythmAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Recommendations for extraction of chronically implanted transvenous pacing and defibrillator leads.Pacing Clin Electrophysiol. 2000; 23: 544-551
- Local symptoms at the site of pacemaker implantation indicate latent systemic infection.Heart. 2004; 8: 882-886
- Is there an adverse outcome from abandoned pacing leads?.J Interv Card Electrophysiol. 2000; 3: 493-499
- Risk factor analysis of permanent pacemaker infection.Clin Infect Dis. 2007; 45: 166-173
- Hands on: how to select patients for lead extraction.Heart Rhythm. 2007; 7: 978-985
- Pacing and implantable cardioverter-defibrillator transvenous lead extraction.Ital Heart J. 2005; 3: 261-266
- Pacemaker and ICD lead extraction with electrosurgical dissection sheaths and standard transvenous extraction systems: results of a randomized trial.Europace. 2007; 2: 98-104
- Permanent pacemaker and implantable cardioverter defibrillator infection: a population based study.Arch Intern Med. 2007; 167: 669-675
- Intravascular pacemaker and defibrillator lead extraction: a state-of-the-art review.Heart Rhythm. 2004; 1: 739-745
- Intravascular extraction of problematic or infected permanent pacemaker leads: 1994–1996. U.S. Extraction Database, MED Institute.Pacing Clin Electrophysiol. 1999; 9: 1348-1357
- Morphologic and immunohistochemical observations of tissues surrounding retrieved transvenous pacemaker leads.J Biomed Mater Res. 2002; 63: 548-558
- Laser assisted lead extraction: the European experience.Europace. 2007; 9: 651-656
- Prevalence and characterization of asymptomatic pacemaker and ICD lead perforation on CT.Pacing Clin Electrophysiol. 2007; 30: 28-32
Article info
Publication history
Published online: September 21, 2007
Identification
Copyright
© 2008 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
